Elsewhere, Milkshake has a story about a biological chemist on a project to develop a delivery vehicle for cancer drugs. This fellow found his results unconvincing, continued working on the problem and ended up demonstrating convincingly that in vivo the vehicle did not behave as intended. Now the company had a problem (the FDA demands that relevant results be reported) because management intended to sell the IP to a hapless bidder, and the chemist's action pierced the veil of plausible deniability: https://orgprepdaily.wordpress.com/2017/08/24/breaking-bad-i...